Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Aggregation of tau protein in the brain is associated with a class of neurodegenerative diseases known as tauopathies. FK506 binding protein 51 kDa (FKBP51, encoded by FKBP5) forms a mature chaperone complex with Hsp90 that prevents tau degradation. In this study, we have shown that tau levels are reduced throughout the brains of Fkbp5-/- mice. Recombinant FKBP51 and Hsp90 synergized to block tau clearance through the proteasome, resulting in tau oligomerization. Overexpression of FKBP51 in a tau transgenic mouse model revealed that FKBP51 preserved the species of tau that have been linked to Alzheimer's disease (AD) pathogenesis, blocked amyloid formation, and decreased tangle load in the brain. Alterations in tau turnover and aggregate structure corresponded with enhanced neurotoxicity in mice. In human brains, FKBP51 levels increased relative to age and AD, corresponding with demethylation of the regulatory regions in the FKBP5 gene. We also found that higher FKBP51 levels were associated with AD progression. Our data support a model in which age-associated increases in FKBP51 levels and its interaction with Hsp90 promote neurotoxic tau accumulation. Strategies aimed at attenuating FKBP51 levels or its interaction with Hsp90 have the potential to be therapeutically relevant for AD and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hsp90:FKBP51 functions in tau proteostasis, increasing its stability and altering phosphorylation states”
From The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state (2021) · cites this paper as Blair et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“since FKBP5 site-specific demethylation occurs with age (49).”
From Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation (2016) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Introduction Neurofibrillary tangles, hallmarks of a class of neurodegenerative diseases termed tauopathies, are comprised of microtubule-associated tau protein aggregates that persist in the brain even after neuron death (1).”
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487 · cited 2×
“3- to 4-times more abundant in cells than 26S proteasomes (35).”
Whitmore, L., & Wallace, B. A. (2008) · Biopolymers · doi:10.1002/bip.20853 · Cited by 2,243
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · cited 1×
“This same model displays cognitive recovery when tau is suppressed, despite continued tangle formation (5, 46).”
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
The Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“However, levels of neuronal death in AD far exceed what is expected based on the observed numbers of tau tangles (2), suggesting that a different mechanism is primarily responsible for neurodegeneration.”
Cited by
Items 301–324 of 324
Dual proximity-based interactome mapping of FKBP51 and FKBP52 uncovers shared metabolic networks
Hill, S. E., Parikh, P., Gebru, N. T., Banjade, S., Guergues, J., Wohlfahrt, J., Stevens, S. M., & Blair, L. J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153968 · Cited by 1
Self-citationJeanne, X., Oberoi, J., Roe, S. M., Baud, M. G. J., Spencer, J., Török, Z., Vígh, L., & Prodromou, C. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100131
Criado‐Marrero, M., Gebru, N. T., Blazier, D. M., Gould, L. A., Baker, J. D., Beaulieu‐Abdelahad, D., & Blair, L. J. (2021) · Figshare · doi:10.6084/m9.figshare.14391487
Self-citationSynergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesisPreprint
Bryan, M. R., Almeida, M. F., Pellegrino, K., Opland, C. K., Paulakonis, J. E., McGillion-Moore, J., Trzeciakiewicz, H., King, D. P., Tian, X., Tseng, J., et al. (2025) · eLife · doi:10.7554/elife.109145 · Cited by 1
Synergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesisPreprint
Bryan, M. R., Almeida, M. F., Pellegrino, K., Opland, C. K., Paulakonis, J. E., McGillion-Moore, J., Trzeciakiewicz, H., King, D. P., Tian, X., Tseng, J., et al. (2025) · eLife · doi:10.7554/elife.109145.1
Gojani, E. G., Farzin, H., Sutherland, R. J., & Mohajerani, M. H. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106619
FKBP5 splice variant alterations in the human cortex of psychiatric disorders
Kaul, D., Edmond, K. Z., Czamara, D., Martinelli, S., Ködel, M., Gassen, N. C., Ran, T. A. O., Kleinman, J. E., Hyde, T. M., Binder, E. B., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.03.016
Self-citationRôle des modifications post-traductionnelles dans le processus d’agrégation de la protéine Tau
Despres, C. (2017) · theses.fr (ABES) · doi:10.70675/de10f843z8572z4295zb672z763dbf30e2b5
Zhang, J., Xiao, Y., Li, A., Ye, J., Zhao, X., Fan, X., & Lu, X. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.04.021
Grabinska-Rogala, A., & Gestwicki, J. E. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_190
Bitar, F. E., Dawsari, G. A., Qadi, N., Rajeh, S. A., Abouelhoda, M., Alsubaie, S., Majrashi, N., Magrashi, A. I., Amari, H. A. A., Alghamdi, F., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1765569
“FKBP5 interferes in tau folding and responds to cellular stress, and it has also been connected to both AD and depression-related traits in tau folding and stress pathways (Blair et al., 2013).”
Wang, M., Xu, Z., Zhang, Y., Jin, X., Liu, X., Liang, X., Guo, C., Liu, X., Dong, B., Fu, C., et al. (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/8262370
FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice
Contreras-Marciales, A., Mezquite-Garcia, D., Verdina, L. A., Elnahrawy, A., Wolf, T., Guergues, J., Parikh, P., Hunter, E. R., Acosta, D. H., Stevens, S. M., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02107-3 · Cited by 1
“This outcome is highly complementary to prior work from our lab demonstrating that over-expression of FKBP51 in the brains of another tau mouse model, rTg4510, promotes tau oligomerization, but does not change the levels of silver-positive, insoluble tau [12].”
InfluentialSelf-citationNeurotoxic Tau Oligomers: Isolation, Preparation, and Characterization
Khan, S., Haque, M. A., & Kayed, R. (2026) · Neuromethods · doi:10.1007/978-1-0716-5234-3_9
Self-citationMathematical mapping of circadian genes in Alzheimer’s disease
Venkatesh, S., Venkadeswaran, K., Raja, R., & Reshma, A. (2026) · Chronobiology International · doi:10.1080/07420528.2026.2705386
Briel, N., Ruf, V., Feyen, P., Roeber, S., Arzberger, T., Windl, O., Weiß, T., Arosio, P., Höglinger, G. U., Struebing, F. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.03.742447 · Cited by 1
“FKBP5 forms a mature chaperone complex with Hsp90 that prevents effective tau degradation and promotes tau oligomerization [45,46].”
Stress and glucocorticoid exposure as a critical environmental risk factor for Alzheimer's disease
Li, X., Greenstein, A., Munro, C. A., Tamashiro, K. L., & Lee, R. S. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579073
Edmond, K. Z., Kaul, D., Yusupov, N., Ködel, M., Sauer, S., Fröhlich, A. S., Kentro, J. A., Ran, T. A. O., Kleinman, J. E., Weinberger, D. R., et al. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250473 · Cited by 3
Self-citationZhang, X., Xu, H., Guo, W., Wang, H.-L., Sun, Z.-H., Liu, Y., Xiao, H.-L., Ji, J., & Sun, X. (2026) · Stroke · doi:10.1161/strokeaha.126.056196
Enzyme−Targeted Therapeutics for Neurological Disorders
Massignan, L., Lokesh, K., Ziadat, S., Uehling, D., Weaver, D. F., & Reed, M. A. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01274
Metadata
- Authors
- Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., Cotman, C., Paulson, H. L., Muschol, M., Uversky, V. N., Klengel, T., Binder, E. B., Kayed, R., Golde, T. E., Berchtold, N., & Dickey, C. A.
- Affiliations
- University of South Florida (US)
- University of Michigan (US)
- University of California, Irvine (US)
- Max Planck Institute of Psychiatry (DE)
- The University of Texas Medical Branch at Galveston (US)
- University of Florida (US)
- Corresponding author
- Wang, Li
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-09-03
- Volume
- 123
- Issue
- 10
- Pages
- 4158-4169
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3784538
- OpenAlex
- W2056613924
- Cited by
- 322
- References
- 72
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 25 · 2023: 28 · 2022: 34 · 2021: 20 · 2020: 24 · 2019: 26 · 2018: 19 · 2017: 18 · 2016: 21 · 2015: 24 · 2014: 23 · 2013: 2
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- American Federation for Aging Research
- BrightFocus Foundation
- University of South Florida
- National Institutes of Health
- University of California, Irvine
- National Institute on Aging (P01AG000538, R01AG034667, P50AG016573)
- National Institute of Neurological Disorders and Stroke (K99NS073936, R00NS073936, R01NS073899, NS073899)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tau oligomerization, tau aggregation, tauopathy, Alzheimer's disease, FKBP51, HSP90, proteasome, tau clearance, amyloid fibril formation, neurotoxicity, tau transgenic mice
- MeSH terms
- Tacrolimus Binding Protein 5, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Animals, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Gene Expression, Case-Control Studies, tau Proteins, Mice, Knockout, HSP90 Heat-Shock Proteins, DNA Methylation, Protein Structure, Quaternary, Tacrolimus Binding Proteins, Proteasome Endopeptidase Complex, Mice, Protein Multimerization, Young Adult, CA3 Region, Hippocampal, HEK293 Cells, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.